decisionhealth Newsletters, Coder Pink Sheets - 2006 Issue 7 (July)
Noridian covers Avastin for AMD
Subscribe or sign in to view the full article.
Article Overview
This article reviews a Noridian Administrative Services policy update on coverage for Avastin in age-related macular degeneration. It is relevant to ophthalmology practices, medical coders, and billing staff who need to understand the general scope of the coverage notice, the associated diagnosis and procedure reporting context, and the states affected by the policy.
Why This Topic Matters
Coverage changes for widely used ophthalmic drugs can affect reimbursement, claim submission, and patient billing workflows. This bulletin also signals how a Medicare contractor addressed documentation and related service reporting for this therapy.
Article Sections
-
Coverage update and policy scope
Summarizes the contractor’s coverage decision, the timing referenced in the notice, and the geographic scope of the policy. It also frames the article’s focus on Avastin use in ophthalmology.
-
Billing and related service guidance
Covers the procedure, drug billing, diagnosis reporting, laterality modifiers, and related documentation context discussed in the bulletin. It also mentions follow-up evaluation services and the supply-management considerations described by the carrier.
What You Will Learn
- How a contractor coverage notice can affect reimbursement for an ophthalmic drug service
- What general billing elements are discussed for the drug and injection encounter
- Which broad diagnosis and service-related topics are tied to the policy
- Which states were included in the coverage area
Who Should Read This
- Ophthalmology coders
- Medical billing staff
- Physician office administrators
- Compliance teams
- Revenue cycle professionals
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com